Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V Trial

Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V Trial

<p>Abstract</p> <p>Background</p> <p>Although the release of cardiac biomarkers after percutaneous (PCI) or surgical revascularization (CABG) is common, its prognostic significance is not known. Questions remain about the mechanisms and degree of correlation between the...

Full description

Bibliographic Details
Main Authors: Hueb Whady, Gersh Bernard J, Rezende Paulo, Garzillo Cibele, Lima Eduardo, Vieira Ricardo, Garcia Rosa Maria, Favarato Desiderio, Segre Carlos Alexandre W, Pereira Alexandre, Soares Paulo, Ribeiro Expedito, Lemos Pedro, Perin Marco A, Strunz Célia, Dallan Luis AO, Jatene Fabio B, Stolf Noedir AG, Hueb Alexandre, Dias Ricardo, Gaiotto Fabio A, da Costa Leandro Menezes, Oikawa Fernando Teiichi, de Melo Rodrigo Morel, Serrano Carlos, de Ávila Luiz Francisco, Villa Alexandre, Filho José Rodrigues, Nomura César, Ramires José AF, Filho Roberto
Format: Article
Language:English
Published: BMC 2012-08-01
Series:BMC Cardiovascular Disorders
Subjects:
Cardiopulmonary bypass
Necrosis markers
Myocardial infarction
PCI
CABG
Online Access:http://www.biomedcentral.com/1471-2261/12/65

Internet

http://www.biomedcentral.com/1471-2261/12/65

Similar Items